Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

PHOENIX -- Matt Hasselbeck took some nasty hits to the head during his 17-year NFL career, four years at Boston College and a childhood full of sports, but the quarterback seems to have emerged from ...

The Career and Technical Education (CTE) Initiative supported by the Trustees Education Initiative (TEI) at the University of Wyoming is dedicated to increasing the number of CTE teachers to support ...

Beverly is a writer, editor, and paralegal specializing in personal finance and tax law. She covers personal financial and legal topics, as well as tax breaks, tax preparation software, and tax law ...

Recursion Pharmaceuticals insiders reported 4 recent transactions totaling $589,430.56. Activity included 2 tax payments and 2 stock sales, with no flagged anomalies. View more Major Holders Insider ...